Office of the Director, National Institutes of Health; Amended Notice of Meeting, 66370 [2013-26432]
Download as PDF
<![CDATA[
66370
Federal Register / Vol. 78, No. 214 / Tuesday, November 5, 2013 / Notices
Dated: October 30, 2013.
Melanie J. Gray,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2013–26428 Filed 11–4–13; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Dated: October 30, 2013.
Melanie J. Gray,
Program Analyst, Office of Federal Advisory
Committee Policy.
National Institute of General Medical
Sciences; Notice of Closed Meetings
wreier-aviles on DSK5TPTVN1PROD with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
General Medical Sciences Special Emphasis
Panel; Peer Review of SCORE Grant
Applications.
Date: November 15, 2013.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Residence Inn Bethesda, 7335
Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Shinako Takada, Ph.D.,
Scientific Review Officer, Office of Scientific
Review, National Institute of General Medical
Sciences, National Institutes of Health, 45
Center Drive, Room 3An.22, Bethesda, MD
20892, 301–594–3663, shinako.takada@
nih.gov.
This meeting notice is being published less
than 15 days in advance of the meeting due
to the Government shutdown of October
2013.
Name of Committee: National Institute of
General Medical Sciences Special Emphasis
Panel; Review of K99 Grant Applications.
Date: November 19, 2013.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Courtyard by Marriott, 5520
Wisconsin Avenue, Chevy Chase, MD 20815.
Contact Person: Robert Horowits, Ph.D.,
Scientific Review Officer, Office of Scientific
Review, National Institute of General Medical
Sciences, National Institutes of Health, 45
Center Drive, Room 3An.18I, Bethesda, MD
20892, 301–594–6904, horowitr@
mail.nih.gov.
This meeting notice is being published less
than 15 days in advance of the meeting due
VerDate Mar<15>2010
15:22 Nov 04, 2013
Jkt 232001
to the Government shutdown of October
2013.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.375, Minority Biomedical
Research Support; 93.821, Cell Biology and
Biophysics Research; 93.859, Pharmacology,
Physiology, and Biological Chemistry
Research; 93.862, Genetics and
Developmental Biology Research; 93.88,
Minority Access to Research Careers; 93.96,
Special Minority Initiatives, National
Institutes of Health, HHS).
[FR Doc. 2013–26421 Filed 11–4–13; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2); notice
is hereby given of the following
meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The purpose of this
meeting is to evaluate requests for
preclinical development resources for
potential new therapeutics for the
treatment of cancer. The outcome of the
evaluation will provide information to
internal NCI committees that will
decide whether NCI should support
requests and make available contract
resources for development of the
potential therapeutic to improve the
treatment of various forms of cancer.
The research proposals and the
discussions could disclose confidential
trade secrets or commercial property
such as patentable material, and
personal information concerning
individuals associated with the
proposed research projects, the
disclosure of which would constitute a
clearly unwarranted invasion of
personal privacy.
Name of Committee: National Cancer
Institute Special Emphasis Panel; NCI
Experimental Therapeutics Program (Cycle
15 NExT).
Date: December 11, 2013.
Time: 8:30 a.m. to 4:30 p.m.
Agenda: To evaluate the NCI Experimental
Therapeutics Program Portfolio.
Place: National Institutes of Health, 9000
Rockville Pike, Building 31 Conference Room
6C06, Bethesda, MD 20892.
PO 00000
Frm 00042
Fmt 4703
Sfmt 9990
Contact Person: Barbara Mroczkowski,
Ph.D., Executive Secretary, Discovery
Experimental Therapeutics Program,
National Cancer Institute, NIH, 31 Center
Drive, Room 3A44 Bethesda, MD 20892,
(301) 496–4291, mroczkoskib@mail.nih.gov.
Joseph Tomaszewski, Ph.D., Executive
Secretary, Development Experimental
Therapeutics Program, National Cancer
Institute, NIH, 31 Center Drive, Room 3A44,
Bethesda, MD 20892, (301) 496–6711,
tomaszej@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health,
HHS).
Dated: October 30, 2013.
Melanie J. Gray,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2013–26426 Filed 11–4–13; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Office of the Director, National
Institutes of Health; Amended Notice
of Meeting
Notice is hereby given of a change in
the meeting of the Office of Research
Infrastructure Programs Special
Emphasis Panel, October 08, 2013, 08:00
a.m. to October 09, 2013, 05:00 p.m.,
Hilton Washington/Rockville, 1750
Rockville Pike, Rockville, MD 20852,
which was published in the Federal
Register on September 16, 2013, 78 FR
56903.
The dates of the meeting are changed
from October 8–9, 2013 to December
10–12, 2013 and changed from an inperson meeting to internet assistant
review. The meeting is closed to the
public.
Dated: October 30, 2013.
David Clary,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2013–26432 Filed 11–4–13; 8:45 am]
BILLING CODE 4140–01–P
E:\FR\FM\05NON1.SGM
05NON1
]]>Agencies
[Federal Register Volume 78, Number 214 (Tuesday, November 5, 2013)]
[Notices]
[Page 66370]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-26432]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Office of the Director, National Institutes of Health; Amended
Notice of Meeting
Notice is hereby given of a change in the meeting of the Office of
Research Infrastructure Programs Special Emphasis Panel, October 08,
2013, 08:00 a.m. to October 09, 2013, 05:00 p.m., Hilton Washington/
Rockville, 1750 Rockville Pike, Rockville, MD 20852, which was
published in the Federal Register on September 16, 2013, 78 FR 56903.
The dates of the meeting are changed from October 8-9, 2013 to
December 10-12, 2013 and changed from an in-person meeting to internet
assistant review. The meeting is closed to the public.
Dated: October 30, 2013.
David Clary,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2013-26432 Filed 11-4-13; 8:45 am]
BILLING CODE 4140-01-P
